# Uber Technologies, Inc: financial statements, quarterly

UBER · NYSE · CIK 1543151 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uber.md) · [Financials](/companies/uber/financials.md) · [Filings](/companies/uber/filings.md) · [Insiders](/companies/uber/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uber/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.3](/filings/0001543151-24-000036.md) | [9.9 d](/filings/0001543151-26-000015.md) | [10.1](/filings/0001543151-25-000015.md) | [10.7](/filings/0001543151-25-000023.md) | [11.2](/filings/0001543151-25-000033.md) | [12.0 d](/filings/0001543151-26-000015.md) | [11.5](/filings/0001543151-26-000022.md) | [12.7](/filings/0001543151-26-000032.md) | [13.5](/filings/0001543151-25-000033.md) | [14.4 d](/filings/0001543151-26-000015.md) | [13.2](/filings/0001543151-26-000022.md) | [14.2](/filings/0001543151-26-000032.md) |
| Research and development | $bn | [0.8](/filings/0001543151-24-000036.md) | [0.8 d](/filings/0001543151-26-000015.md) | [0.8](/filings/0001543151-25-000015.md) | [0.8](/filings/0001543151-25-000023.md) | [0.8](/filings/0001543151-25-000033.md) | [0.8 d](/filings/0001543151-26-000015.md) | [0.8](/filings/0001543151-26-000022.md) | [0.8](/filings/0001543151-26-000032.md) | [0.9](/filings/0001543151-25-000033.md) | [0.9 d](/filings/0001543151-26-000015.md) | [1.0](/filings/0001543151-26-000022.md) | [1.0](/filings/0001543151-26-000032.md) |
| Operating income | $bn | [0.4](/filings/0001543151-24-000036.md) | [0.7 d](/filings/0001543151-26-000015.md) | [0.2](/filings/0001543151-25-000015.md) | [0.8](/filings/0001543151-25-000023.md) | [1.1](/filings/0001543151-25-000033.md) | [0.8 d](/filings/0001543151-26-000015.md) | [1.2](/filings/0001543151-26-000022.md) | [1.5](/filings/0001543151-26-000032.md) | [1.1](/filings/0001543151-25-000033.md) | [1.8 d](/filings/0001543151-26-000015.md) | [1.9](/filings/0001543151-26-000022.md) | [1.9](/filings/0001543151-26-000032.md) |
| Interest expense | $bn | [0.2](/filings/0001543151-23-000039.md) | [0.2 d](/filings/0001543151-24-000012.md) | [0.1](/filings/0001543151-24-000020.md) | [0.1](/filings/0001543151-25-000023.md) | [0.1](/filings/0001543151-25-000033.md) | [0.1 d](/filings/0001543151-26-000015.md) | [0.1](/filings/0001543151-26-000022.md) | [0.1](/filings/0001543151-26-000032.md) | [0.1](/filings/0001543151-25-000033.md) | [0.1 d](/filings/0001543151-26-000015.md) | [0.1](/filings/0001543151-26-000022.md) | [0.1](/filings/0001543151-26-000032.md) |
| Income tax | $bn | [(0.0)](/filings/0001543151-24-000036.md) | [0.1 d](/filings/0001543151-26-000015.md) | [0.0](/filings/0001543151-25-000015.md) | [0.1](/filings/0001543151-25-000023.md) | [0.2](/filings/0001543151-25-000033.md) | [(6.0) d](/filings/0001543151-26-000015.md) | [(0.4)](/filings/0001543151-26-000022.md) | [0.1](/filings/0001543151-26-000032.md) | [(4.0)](/filings/0001543151-25-000033.md) | [(0.0) d](/filings/0001543151-26-000015.md) | [0.2](/filings/0001543151-26-000022.md) | [0.8](/filings/0001543151-26-000032.md) |
| Net income | $bn | [0.2](/filings/0001543151-24-000036.md) | [1.4 d](/filings/0001543151-26-000015.md) | [(0.7)](/filings/0001543151-25-000015.md) | [1.0](/filings/0001543151-25-000023.md) | [2.6](/filings/0001543151-25-000033.md) | [6.9 d](/filings/0001543151-26-000015.md) | [1.8](/filings/0001543151-26-000022.md) | [1.4](/filings/0001543151-26-000032.md) | [6.6](/filings/0001543151-25-000033.md) | [0.3 d](/filings/0001543151-26-000015.md) | [0.3](/filings/0001543151-26-000022.md) | [2.4](/filings/0001543151-26-000032.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001543151-24-000036.md) | not reported | [(0.32)](/filings/0001543151-25-000015.md) | [0.47](/filings/0001543151-25-000023.md) | [1.20](/filings/0001543151-25-000033.md) | not reported | [0.83](/filings/0001543151-26-000022.md) | [0.63](/filings/0001543151-26-000032.md) | [3.11](/filings/0001543151-25-000033.md) | not reported | [0.13](/filings/0001543151-26-000022.md) | [1.17](/filings/0001543151-26-000032.md) |
| Basic EPS | $ per share | [0.11](/filings/0001543151-24-000036.md) | not reported | [(0.31)](/filings/0001543151-25-000015.md) | [0.49](/filings/0001543151-25-000023.md) | [1.24](/filings/0001543151-25-000033.md) | not reported | [0.85](/filings/0001543151-26-000022.md) | [0.65](/filings/0001543151-26-000032.md) | [3.18](/filings/0001543151-25-000033.md) | not reported | [0.13](/filings/0001543151-26-000022.md) | [1.18](/filings/0001543151-26-000032.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.4](/filings/0001543151-24-000036.md) | [4.7](/filings/0001543151-26-000015.md) | [5.0](/filings/0001543151-25-000015.md) | [4.5](/filings/0001543151-25-000023.md) | [6.2](/filings/0001543151-25-000033.md) | [5.9](/filings/0001543151-26-000015.md) | [5.1](/filings/0001543151-26-000022.md) | [6.4](/filings/0001543151-26-000032.md) | [8.4](/filings/0001543151-25-000033.md) | [7.1](/filings/0001543151-26-000032.md) | [5.6](/filings/0001543151-26-000022.md) | [4.9](/filings/0001543151-26-000032.md) |
| Current assets | $bn | [10.7](/filings/0001543151-23-000039.md) | [11.3](/filings/0001543151-25-000008.md) | [12.1](/filings/0001543151-24-000020.md) | [12.5](/filings/0001543151-24-000027.md) | [15.3](/filings/0001543151-24-000036.md) | [12.2](/filings/0001543151-26-000015.md) | [12.4](/filings/0001543151-25-000015.md) | [14.1](/filings/0001543151-25-000023.md) | [15.1](/filings/0001543151-25-000033.md) | [14.0](/filings/0001543151-26-000032.md) | [12.8](/filings/0001543151-26-000022.md) | [12.5](/filings/0001543151-26-000032.md) |
| Total assets | $bn | [35.9](/filings/0001543151-23-000039.md) | [38.7](/filings/0001543151-25-000008.md) | [39.6](/filings/0001543151-24-000020.md) | [41.5](/filings/0001543151-24-000027.md) | [47.1](/filings/0001543151-24-000036.md) | [51.2](/filings/0001543151-26-000015.md) | [52.8](/filings/0001543151-25-000015.md) | [56.0](/filings/0001543151-25-000023.md) | [63.3](/filings/0001543151-25-000033.md) | [61.8](/filings/0001543151-26-000032.md) | [59.9](/filings/0001543151-26-000022.md) | [65.8](/filings/0001543151-26-000032.md) |
| Current liabilities | $bn | [9.4](/filings/0001543151-23-000039.md) | [9.5](/filings/0001543151-25-000008.md) | [10.0](/filings/0001543151-24-000020.md) | [10.3](/filings/0001543151-24-000027.md) | [10.8](/filings/0001543151-24-000036.md) | [11.5](/filings/0001543151-26-000015.md) | [12.1](/filings/0001543151-25-000015.md) | [12.7](/filings/0001543151-25-000023.md) | [13.1](/filings/0001543151-25-000033.md) | [12.3](/filings/0001543151-26-000032.md) | [12.0](/filings/0001543151-26-000022.md) | [14.9](/filings/0001543151-26-000032.md) |
| Total liabilities | $bn | [25.4](/filings/0001543151-23-000039.md) | [26.0](/filings/0001543151-25-000008.md) | [27.1](/filings/0001543151-24-000020.md) | [27.7](/filings/0001543151-24-000027.md) | [30.6](/filings/0001543151-24-000036.md) | [28.8](/filings/0001543151-26-000015.md) | [29.9](/filings/0001543151-25-000015.md) | [32.4](/filings/0001543151-25-000023.md) | [34.2](/filings/0001543151-25-000033.md) | [33.7](/filings/0001543151-26-000032.md) | [34.1](/filings/0001543151-26-000022.md) | [37.4](/filings/0001543151-26-000032.md) |
| Long-term debt | $bn | [9.3](/filings/0001543151-23-000039.md) | [9.5](/filings/0001543151-25-000008.md) | [9.5](/filings/0001543151-24-000020.md) | [9.5](/filings/0001543151-24-000027.md) | [11.0](/filings/0001543151-24-000036.md) | [8.3](/filings/0001543151-26-000015.md) | [8.4](/filings/0001543151-25-000015.md) | [9.6](/filings/0001543151-25-000023.md) | [10.6](/filings/0001543151-25-000033.md) | [10.5](/filings/0001543151-26-000032.md) | [10.5](/filings/0001543151-26-000022.md) | [10.7](/filings/0001543151-26-000032.md) |
| Current portion of debt | $bn | [0.0](/filings/0001543151-23-000039.md) | [0.0](/filings/0001543151-25-000008.md) | [0.0](/filings/0001543151-24-000020.md) | [0.0](/filings/0001543151-24-000027.md) | [0.5](/filings/0001543151-24-000036.md) | [1.2](/filings/0001543151-26-000015.md) | [1.2](/filings/0001543151-25-000015.md) | [1.2](/filings/0001543151-25-000023.md) | [1.2](/filings/0001543151-25-000033.md) | [0.0](/filings/0001543151-26-000015.md) | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001543151-25-000023.md) | [0.0](/filings/0001543151-25-000033.md) | [0.0](/filings/0001543151-26-000032.md) | [0.0](/filings/0001543151-26-000022.md) | [2.0](/filings/0001543151-26-000032.md) |
| Shareholders' equity | $bn | [9.4](/filings/0001543151-23-000039.md) | [11.2](/filings/0001543151-25-000008.md) | [11.1](/filings/0001543151-24-000020.md) | [12.4](/filings/0001543151-24-000027.md) | [14.8](/filings/0001543151-24-000036.md) | [21.6](/filings/0001543151-26-000015.md) | [22.0](/filings/0001543151-25-000015.md) | [22.6](/filings/0001543151-25-000023.md) | [28.1](/filings/0001543151-25-000033.md) | [27.0](/filings/0001543151-26-000032.md) | [24.8](/filings/0001543151-26-000022.md) | [27.3](/filings/0001543151-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper, us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [966 d](/filings/0001543151-24-000036.md) | [823 d](/filings/0001543151-26-000015.md) | [1,416](/filings/0001543151-25-000015.md) | [1,820 d](/filings/0001543151-25-000023.md) | [2,151 d](/filings/0001543151-25-000033.md) | [1,750 d](/filings/0001543151-26-000015.md) | [2,324](/filings/0001543151-26-000022.md) | [2,564 d](/filings/0001543151-26-000032.md) | [2,328 d](/filings/0001543151-25-000033.md) | [2,883 d](/filings/0001543151-26-000015.md) | [2,351](/filings/0001543151-26-000022.md) | [2,862 d](/filings/0001543151-26-000032.md) |
| Capital expenditure | $m | [61.0 d](/filings/0001543151-24-000036.md) | [55.0 d](/filings/0001543151-26-000015.md) | [57.0](/filings/0001543151-25-000015.md) | [99.0 d](/filings/0001543151-25-000023.md) | [42.0 d](/filings/0001543151-25-000033.md) | [44.0 d](/filings/0001543151-26-000015.md) | [74.0](/filings/0001543151-26-000022.md) | [89.0 d](/filings/0001543151-26-000032.md) | [98.0 d](/filings/0001543151-25-000033.md) | [75.0 d](/filings/0001543151-26-000015.md) | [65.0](/filings/0001543151-26-000022.md) | [70.0 d](/filings/0001543151-26-000032.md) |
| Share repurchases | $m | [0.0 d](/filings/0001543151-24-000036.md) | [0.0 d](/filings/0001543151-26-000015.md) | [0.0](/filings/0001543151-25-000015.md) | [325 d](/filings/0001543151-25-000023.md) | [372 d](/filings/0001543151-25-000033.md) | [555 d](/filings/0001543151-26-000015.md) | [1,785](/filings/0001543151-26-000022.md) | [1,363 d](/filings/0001543151-26-000032.md) | [1,463 d](/filings/0001543151-25-000033.md) | [1,912 d](/filings/0001543151-26-000015.md) | [3,011](/filings/0001543151-26-000022.md) | [518 d](/filings/0001543151-26-000032.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,979](/filings/0001543151-23-000039.md) | [2,010](/filings/0001543151-24-000020.md) | [2,079](/filings/0001543151-24-000027.md) | [2,108](/filings/0001543151-24-000036.md) | [2,080](/filings/0001543151-25-000015.md) | [2,150](/filings/0001543151-25-000023.md) | [2,154](/filings/0001543151-25-000033.md) | [2,123](/filings/0001543151-26-000022.md) | [2,126](/filings/0001543151-26-000032.md) | [2,124](/filings/0001543151-25-000033.md) | [2,071](/filings/0001543151-26-000022.md) | [2,050](/filings/0001543151-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,042,560,121 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001543151-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.